Friday, Dec 09, 2022
×
Outlook.com
×

Lupin Shares Fell

Lupin Gets USFDA Nod To Market Generic Drug

The company has received tentative approval from the United States Food and Drug Administration for its abbreviated new drug application for Tenofovir Alafenamide tablets

18 April 2022

Lupin Gets USFDA Nod For Generic Product

The Mumbai-based company's product is the generic version of Viatris Specialty LLC's Revatio


Lupin Receives USFDA Approval For Anti-Depressant Drug

The approval granted by the US Food and Drug Administration is for the abbreviated new drug application Desvenlafaxine extended-release tablets of strength 25 mg, the company said in a regulatory filing.

14 April 2022

Buzzing Stocks: PNB Shares Tumble Nearly 10 Per Cent, Lupin Plunges falls Over 2 Per Cent

The state-owned bank reported a 78 per cent rise in net profit to Rs 1,105 crore for the second quarter ended on September 30 despite a fall in income.


Lupin Launches Generic Contraceptive Drug In US

The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC

07 April 2022

Advertisement

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement